Monster Beverage: Short Interest Spikes but Lenders Stay Relaxed

Monster Beverage enters the back half of August with a striking contradiction at its core: short interest has nearly doubled in a month while the borrow market remains among the most ample in the large-cap beverage universe.

The short interest story is the week's headline number, even if the full picture is more nuanced. Estimated SI jumped 72% week-on-week to reach 3.7% of the free float — up from roughly 2.1% a month ago — making it the sharpest build in positioning the stock has seen in recent memory. The surge is eye-catching in absolute terms, particularly when set against the context of a stock that has fallen 52% over the past month to close at $46.86. Yet the borrow market tells a very different story. Availability remains extraordinarily loose at over 7,300% — meaning lenders hold roughly 73 times more shares than are currently borrowed. Cost to borrow is just 0.37%, up about 45% on the week but still firmly in "almost free" territory. This is not a supply-constrained short thesis; it is an open-door trade.

Options positioning has rotated sharply toward call-side optimism, which cuts against the rising short interest. The put/call ratio is running at its lowest level of the past year — 0.67 versus a 20-day average of 0.80 — and has been declining steadily all week after a brief spike to 1.74 on August 11 (likely a post-earnings hedging flush). That call-heavy tilt suggests a meaningful cohort of market participants is positioned for recovery even as the short position rebuilds. The two signals are in direct tension: shorts are adding exposure while options traders buy calls on a stock trading near multi-year lows.

The analyst community is largely aligned with the bulls, though there is a critical data-consistency caveat worth naming. Following the August 6 earnings print, several firms raised targets — UBS to $105, RBC Capital to $100, Piper Sandler to $101, and Evercore ISI to $105 — all while maintaining positive or neutral ratings. The consensus mean price target sits near $50, which is close to the current price. But most of those targets were set against a stock that was trading in the $85-$100 range just weeks ago and has since been cut in half; the post-crash target revisions that would normally follow do not yet appear in the data. Treat the consensus figure as stale pending the next round of updates. What is clear is that the bull case rests on the Coca-Cola distribution partnership, international growth, and the zero-sugar product line, while bears focus on international execution risk, margin pressure, and a valuation still running at 37x trailing earnings despite the selloff.

The earnings history gives the next catalyst its context. The August 6 print drove a 4.3% single-day decline and a devastating 50.6% five-day loss — the latter figure almost certainly capturing the full extent of the collapse from pre-announcement highs into the post-results repricing. The next earnings event is scheduled for November 5. The ORTEX short score has drifted lower all week, from 40.6 on August 14 to 37.5 on August 27, ranking in the 42nd percentile — moderate, not extreme. That reading suggests the market is not yet treating MNST as a speculative short-squeeze candidate, even as the share count borrowed climbs. Among peers, KO fell 1.6% on the week, broadly in line with Monster's 1.9% decline, while KDP managed a small gain of 0.4% — a mild divergence that highlights Monster's continued relative weakness rather than any sector-wide shock.

The November 5 earnings date is now the dominant event on the calendar, and what to watch between now and then is whether the short interest build sustains or reverses as the post-crash dust settles — and whether analyst target resets close the gap between the current price and the still-elevated consensus.